This week FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss US approval of the first new lupus therapy in a decade, Eli Lilly’s optimistic body language about bringing a new Alzheimer’s disease treatment to market next year and Sanofi’s acquisition of messenger RNA specialist Translate Bio.